97,600 Shares in Kenvue Inc. $KVUE Acquired by Louisiana State Employees Retirement System

by · The Cerbat Gem

Louisiana State Employees Retirement System bought a new position in shares of Kenvue Inc. (NYSE:KVUE – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 97,600 shares of the company’s stock, valued at approximately $1,683,000.

A number of other large investors have also made changes to their positions in the stock. Physician Wealth Advisors Inc. grew its stake in shares of Kenvue by 67.5% in the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after buying an additional 618 shares during the period. Elyxium Wealth LLC purchased a new stake in shares of Kenvue during the 4th quarter valued at approximately $26,000. MV Capital Management Inc. acquired a new position in Kenvue in the fourth quarter valued at approximately $28,000. Reflection Asset Management acquired a new position in Kenvue in the fourth quarter valued at approximately $32,000. Finally, SBI Securities Co. Ltd. grew its position in Kenvue by 82.4% in the fourth quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock worth $39,000 after acquiring an additional 1,027 shares during the period. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.59% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms have commented on KVUE. Citigroup decreased their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Barclays cut their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. Argus upgraded shares of Kenvue to a “hold” rating in a research note on Friday, March 6th. Zacks Research upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 8th. Finally, UBS Group lowered their target price on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $19.33.

Read Our Latest Report on Kenvue

Kenvue Stock Up 1.1%

KVUE stock opened at $19.33 on Thursday. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $22.87. The company has a market cap of $37.11 billion, a price-to-earnings ratio of 22.74, a price-to-earnings-growth ratio of 1.45 and a beta of 0.54. The company has a fifty day moving average price of $17.76 and a 200 day moving average price of $17.68. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70.

Kenvue (NYSE:KVUE – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The firm had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. During the same quarter in the previous year, the firm earned $0.24 earnings per share. The firm’s revenue was up 4.5% on a year-over-year basis. Sell-side analysts expect that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were issued a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.3%. The ex-dividend date was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is presently 97.65%.

Kenvue Profile

(Free Report)

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Featured Stories

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE – Free Report).